145 related articles for article (PubMed ID: 29472602)
41. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
Yang L; Yi K; Wang H; Zhao Y; Xi M
Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
[TBL] [Abstract][Full Text] [Related]
42. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
Paaso A; Jaakola A; Syrjänen S; Louvanto K
Acta Cytol; 2019; 63(2):148-158. PubMed ID: 30783048
[TBL] [Abstract][Full Text] [Related]
43. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
44. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
45. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
46. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
47. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
48. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
Talora C; Sgroi DC; Crum CP; Dotto GP
Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
[TBL] [Abstract][Full Text] [Related]
49. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
[TBL] [Abstract][Full Text] [Related]
50. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations.
Henken FE; De-Castro Arce J; Rösl F; Bosch L; Meijer CJ; Snijders PJ; Steenbergen RD
Cell Oncol (Dordr); 2012 Apr; 35(2):77-84. PubMed ID: 22271085
[TBL] [Abstract][Full Text] [Related]
51. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
Qi SY; Yang MM; Li CY; Yu K; Deng SL
Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
[TBL] [Abstract][Full Text] [Related]
52. Innate immunity and HPV: friends or foes.
Nunes RAL; Morale MG; Silva GÁF; Villa LL; Termini L
Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e549s. PubMed ID: 30328949
[TBL] [Abstract][Full Text] [Related]
53. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
[TBL] [Abstract][Full Text] [Related]
54. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract][Full Text] [Related]
55. Sarm1/Myd88-5 Regulates Neuronal Intrinsic Immune Response to Traumatic Axonal Injuries.
Wang Q; Zhang S; Liu T; Wang H; Liu K; Wang Q; Zeng W
Cell Rep; 2018 Apr; 23(3):716-724. PubMed ID: 29669278
[TBL] [Abstract][Full Text] [Related]
56. Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.
Uccellini MB; Bardina SV; Sánchez-Aparicio MT; White KM; Hou YJ; Lim JK; García-Sastre A
Cell Rep; 2020 Apr; 31(1):107498. PubMed ID: 32268088
[TBL] [Abstract][Full Text] [Related]
57. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract][Full Text] [Related]
58. The immune response to papillomavirus during infection persistence and regression.
Hibma MH
Open Virol J; 2012; 6():241-8. PubMed ID: 23341859
[TBL] [Abstract][Full Text] [Related]
59. Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways.
Pérez-Plasencia C; Vázquez-Ortiz G; López-Romero R; Piña-Sanchez P; Moreno J; Salcedo M
Infect Agent Cancer; 2007 Sep; 2():16. PubMed ID: 17822553
[TBL] [Abstract][Full Text] [Related]
60. Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression.
Słotwiński R; Dąbrowska A; Lech G; Słodkowski M; Słotwińska SM
Cent Eur J Immunol; 2014; 39(4):498-507. PubMed ID: 26155170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
